Q Therapeutics, a cell therapy company focusing on neural applications, recently announced a $15M series B financing that included funding from multiple venture capital (VC) groups as well as biotech … more →
The Regeneration StationG to the C wrote 1 year ago: Just an update on professional front for a change. An article written by me was recently published i … more →
danmcgirt wrote 1 year ago: This edition of BIOtech Now considers the role of advanced biofuels in meeting the challenge of glob … more →
jrowley wrote 1 year ago: Q Therapeutics, a cell therapy company focusing on neural applications, recently announced a $15M se … more →
jrowley wrote 1 year ago: Cytori Therapeutics announced that they have enrolled their first two patients in an acute myocardia … more →
jrowley wrote 1 year ago: You have to hand it to Tengion, they are trying to tackle one of the largest challenges I can think … more →
jrowley wrote 1 year ago: Pervasis Therapeutics announced that they have raised $9.75M to further develop their allogenic tiss … more →
jrowley wrote 1 year ago: The WuXi acquisition of Apptec (posted last week) is continuing the trend of consolidation in the ce … more →
jrowley wrote 1 year ago: WuXi (pronounced Woo-See) Pharmatech, a contract research organization (CRO) based in China, announc … more →
jrowley wrote 1 year ago: There have been some interesting news releases this week, including Osiris’ fast track designa … more →
jrowley wrote 1 year ago: Organogenesis, one of the pioneering tissue engineering companies, is partnering with China’s … more →
jrowley wrote 1 year ago: One of the aspects of my science career that I really enjoy is the career coaching that I provide, a … more →
jrowley wrote 2 years ago: I have been playing with the idea of a post related to the area of therapeutic cell bioprocessing, a … more →